Tonghua Dongbao Pharmaceutical Co., Ltd.

Sembol: 600867.SS

SHH

10.3

CNY

Bugünkü piyasa fiyatı

  • 18.2244

    F/K Oranı

  • 0.0089

    PEG Oranı

  • 20.25B

    MRK Kapağı

  • 0.02%

    DIV Verimi

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) Finansal Tablolar

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Bilanço

Tonghua Dongbao Pharmaceutical Co., Ltd.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

01159.7846.5902
743.7
368
356
336.4
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
18.6
9.5
8.9
28.3
14.3
4.1
19
6.1
9.8
54.1
132.6
161.2
17.1
34.6
0

balance-sheet.row.short-term-investments

055.558.537
150.4
-73
-58.8
-29.7
-14.7
-16.3
-17.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0916.8515.4707.3
623.7
724.2
677.2
605.3
519.3
455.7
480.2
535.1
595.5
712.1
560
618.3
626.4
544.2
515.7
835.4
834.4
969.9
1021.6
850.2
127.5
131.8
0.4
0.2
4.1
5.6
0

balance-sheet.row.inventory

0705.3653.9537.9
537.6
628.8
901
973.9
1047.9
954.8
629.6
343.8
233
197.8
187.4
170.1
145.6
145.5
140.1
139.8
140.6
126.6
95.9
98.5
73
53.4
35.1
23.9
25.3
13.4
0

balance-sheet.row.other-current-assets

034.540.515.2
17.4
205.6
339
324.3
406.9
11.2
0.1
12.5
-84.5
-99.9
-79.2
-113.6
-119.4
-89.2
-77.2
-218.5
-248.9
-310.9
-347.8
-220.4
642.3
664.2
526.3
488
258.1
192.1
205.6

balance-sheet.row.total-current-assets

02816.42056.42162.5
1922.4
1926.6
2273.2
2240
2209.8
1633.9
1311.8
1107.4
868.6
1053.9
731
721.5
671.2
610
587.6
785
740.3
789.7
788.8
734.3
852.6
903.5
694.5
673.4
304.6
245.7
205.6

balance-sheet.row.property-plant-equipment-net

02704.42678.42392.1
2287.6
2111
1959.7
1873.4
1851.4
1586.9
1279.9
1259.7
1233.2
1087.1
1147.9
1180.2
1226.9
1224.2
1099.5
873.7
807.7
732.1
673.1
622.3
515.2
478.9
387
185.3
174.5
75.7
43.5

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
4.8
4.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

01338.31069.1796.6
608.8
472.6
388.6
193.6
198.7
102
81.8
80.9
69.1
69.5
77.8
84.9
93.3
104.3
94.3
23.9
32
31.2
30.6
34.7
33
72.1
73.2
9.1
9.8
5.6
0

balance-sheet.row.goodwill-and-intangible-assets

01338.31069.1796.6
608.8
472.6
388.6
193.6
198.7
102
81.8
80.9
69.1
69.5
77.8
84.9
98.2
109.2
94.3
23.9
32
31.2
30.6
34.7
33
72.1
73.2
9.1
9.8
5.6
0

balance-sheet.row.long-term-investments

0534.2304420.9
311.4
428.8
385
368.3
334.3
195.5
246.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

038.646.242.4
37.7
37.8
36.2
39
44.1
44
35.6
28.4
30.5
21
20.7
20.7
21.6
28.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0339.6596.2705.6
635.3
373.1
420.6
38.4
36.8
225.8
0.5
218
178.8
145.8
209
244.2
153.4
297.5
185.7
202.3
226.2
242.1
76.1
65.2
68.3
42.9
24
7.5
7
0.5
17.4

balance-sheet.row.total-non-current-assets

049554693.94357.6
3880.8
3423.3
3190.1
2512.7
2465.2
2154.3
1644.5
1587
1511.5
1323.4
1455.3
1530
1500.1
1659
1379.5
1099.9
1065.9
1005.4
779.8
722.2
616.5
593.9
484.2
201.9
191.3
81.8
60.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.2
0
0
0

balance-sheet.row.total-assets

07771.46750.36520.1
5803.3
5349.9
5463.3
4752.7
4675
3788.1
2956.2
2694.5
2380.1
2377.3
2186.3
2251.4
2171.3
2269
1967.1
1885
1806.2
1795.1
1568.5
1456.5
1469.1
1497.4
1178.7
875
495.9
327.5
266.5

balance-sheet.row.account-payables

0115.980.975
68.2
69.2
132
61.3
90.5
53.2
52
38.9
30.8
37.8
46.7
40.7
49.5
40.8
43.1
44.4
45.2
40.7
39.7
29.3
28.7
19.9
25
20.5
20.7
13.6
0

balance-sheet.row.short-term-debt

0150-21.1-7.9
-8.2
125
450
0
430
872.8
310
283
79
93
64
223
321.7
324.1
251.7
337.9
271.5
249.2
3.2
3.2
3.4
45.9
23
1.7
7.3
0
0

balance-sheet.row.tax-payables

052.513.2111.6
55.5
50.9
40
34.7
20.4
11.7
15.5
14.9
-5.5
4.3
20.5
4
8
12.2
33.7
27.1
17.8
8.8
13.5
4.6
-1.4
-1.2
3.8
3.8
3.9
5.4
0

balance-sheet.row.long-term-debt-total

002.62.6
2.6
2.6
4
0
60
250
298
256.4
238.8
122
266.6
269.1
269.6
270.1
270.1
48.2
99.5
49.5
49.5
0
0
14.3
15
28.6
11.5
0
0

Deferred Revenue Non Current

027.528.528.7
32.9
33.4
33.7
35
24.2
24.5
24
-211.4
-226.9
-108.9
-252.1
-251.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0243.881.2193.6
140
29.9
69.4
113.7
5.4
2
3.3
16.3
11.8
12.1
9
11.8
6.8
6.5
6.4
2.7
9.4
6.3
3.9
6.5
2.9
0.5
1
0.8
1.1
60.3
23.5

balance-sheet.row.total-non-current-liabilities

07.438.731.3
35.6
36.3
37.7
40.3
90.7
282.4
335.1
303.2
252.9
136
284.6
303.5
312.9
313.4
315.6
94
100.3
50.9
52
1.7
0
14.4
15
28.6
11.5
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0527.6200.7299.9
243.8
341.1
729.1
215.3
729.8
1309.1
795.7
678.2
388.9
299.4
453.7
624.7
737.7
735
691.1
544.2
480.1
393.9
205.5
78
44.1
92.8
249.8
64.7
51.6
73.9
23.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01993.61993.72034
2034
2034
2034
1711.3
1421.9
1135.8
1030.1
931.5
776.2
776.2
575
479.1
368.6
368.6
368.6
324.5
324.5
324.5
324.5
324.5
324.5
324.5
208
208
115.6
92.4
77.8

balance-sheet.row.retained-earnings

03697.43025.52700.5
1951.1
1531.1
1208.4
1130.3
942.3
819.9
686.3
716.5
708.3
808.8
482.7
320.1
252.8
212.2
110.5
100.3
87.6
167.8
138.5
190
234.5
196.6
170
91.9
73.8
5.7
26.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

01003.41188.11039.9
863.5
662.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0516.8336.9440.4
705.5
772.5
1481.9
1686.3
1575
503.6
421.4
343.2
477.2
461
641.9
793.6
772.4
911.2
754
871.4
867.8
865.9
859.1
857.6
859
850.6
524.9
510.5
255
155.5
138.5

balance-sheet.row.total-stockholders-equity

07211.26544.36214.9
5554
5000.4
4724.3
4527.9
3939.2
2459.3
2137.7
1991.2
1961.7
2046
1699.6
1592.9
1393.8
1492
1233.1
1296.1
1279.9
1358.2
1322
1372.1
1417.9
1371.6
902.9
810.3
444.4
253.6
243

balance-sheet.row.total-liabilities-and-stockholders-equity

07771.46750.36520.1
5803.3
5349.9
5463.3
4752.7
4675
3788.1
2956.2
2694.5
2380.1
2377.3
2186.3
2251.4
2171.3
2269
1967.1
1885
1806.2
1795.1
1568.5
1456.5
1469.1
1497.4
1178.7
875
495.9
327.5
266.5

balance-sheet.row.minority-interest

05.15.35.3
5.5
8.4
10
9.6
6
19.7
22.8
25
29.5
31.9
32.9
33.8
39.8
42
42.9
44.6
46.2
43
41
6.5
7.1
33
26
0
0
0
0

balance-sheet.row.total-equity

07216.36549.66220.2
5559.5
5008.8
4734.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0589.8362.5457.9
461.8
355.8
326.2
338.6
319.6
179.2
228.8
213.4
173
138.9
209
244.2
153.4
297.5
162.3
202.3
226.2
242.1
76.1
65.2
63.9
38.4
21.7
0
0
0.5
0

balance-sheet.row.total-debt

01502.62.6
2.6
125
450
0
490
1122.8
608
539.4
317.8
215
330.6
492.1
591.3
594.1
521.8
386.1
371
298.7
52.7
3.2
3.4
60.2
38
30.3
18.9
0
0

balance-sheet.row.net-debt

0-954.2-785.4-862.4
-590.7
-243
94
-336.4
254.4
910.6
406.1
323.3
193.2
-29
267.8
445.4
572.6
584.6
512.9
357.7
356.7
294.6
33.7
-2.9
-6.4
6.1
-94.6
-130.9
1.8
-34.6
0

Nakit Akış Tablosu

Tonghua Dongbao Pharmaceutical Co., Ltd.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

01167.81581.81308.6
930.3
809.6
838.9
840.1
639.2
490.1
276.5
179.5
59.6
363
173.4
67.7
44.6
75.7
13.3
18
-74.8
38.2
44.4
31
48
71.5
90.7

cash-flows.row.depreciation-and-amortization

0207.1151.2143.7
154.5
152.8
172
166.5
160.4
130.8
112.8
108.3
107.6
106.7
103.5
89
72.8
69
64
57.9
48.9
46.9
37.9
27.1
26.5
30.9
17.2

cash-flows.row.deferred-income-tax

07.53.7-4.7
0.2
-1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-863.734.147.7
3.5
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-449.572.6-48.4
82.7
96.8
-34.7
-65
-140.3
-332
-228.2
-88.5
-59
-156.9
3.6
-33.1
-62.8
-1.1
68
1.8
-62.9
-44.5
-41.7
59.3
-46.3
-197.8
-314.4

cash-flows.row.account-receivables

0-430.9140.6-97.7
2.3
-43.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-55.5-124.7-3.4
97.3
269.7
73.7
71.9
-99.4
-330.1
-287
-110.4
-28.6
-3.3
-17.3
-31.5
-0.1
-5.4
-0.3
0.8
-14
-30.7
2.6
-25.5
-24.7
-18.3
-11.1

cash-flows.row.account-payables

03752.957.5
-17.1
-128.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

003.7-4.7
0.2
-1.3
-108.4
-136.9
-40.9
-2
58.7
21.9
-30.4
-153.6
20.9
-1.6
-62.7
4.2
68.4
1
-48.9
-13.9
-44.3
84.8
-21.7
-179.4
-303.2

cash-flows.row.other-non-cash-items

0815.4-980.3-312.3
21.1
93
-99.2
19.6
66.5
5.7
44.8
21.9
86.1
-367.8
-120.1
42.6
37.7
-22.6
12.7
14.5
102
4.9
-8.6
0.3
0.9
0.2
-10.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-348.1-491.6-600.7
-479.6
-293.1
-773.1
-185.5
-411.5
-400.1
-106.1
-190.4
-241.8
-88.8
-72.7
-79.1
-56.7
-258.3
-286.9
-119.4
-49.1
-57.9
-89.4
-88.7
-52.5
-241
-16.5

cash-flows.row.acquisitions-net

00.4020.4
-28.1
0
778.4
0.2
412.1
-0.1
0
0
241.9
0
73.2
19.7
0
0
0
0
0
0
0
0
0
241
0.1

cash-flows.row.purchases-of-investments

0-238.1-1153.5-844.5
-510
-438
-518
-1244
-738.9
-1.8
0
-34.4
-17.2
0
-36.1
79.4
0
0
-9.7
0
-6.9
-161.9
-9.5
0
0
-2.5
-28.9

cash-flows.row.sales-maturities-of-investments

0240.61992.81458.9
399.9
579.1
536
1321.2
312.1
48.7
0
0
14.1
456.2
143.9
51.3
0
84.8
0
0
0
0
0
0
0
0.5
0

cash-flows.row.other-investing-activites

00-3.70
1.2
-0.4
-773.1
1.7
-411.5
-225.2
0
56.4
-241.8
0.1
-72.7
-79.1
0
0
0
0
0
0
0.5
0
-1
-241
4.2

cash-flows.row.net-cash-used-for-investing-activites

0-345.234434.1
-616.6
-152.5
-749.7
-106.5
-837.9
-578.4
-106
-168.3
-244.9
367.4
35.7
-7.7
-56.7
-173.5
-296.6
-119.4
-55.9
-219.8
-98.4
-88.7
-53.5
-242.9
-41.1

cash-flows.row.debt-repayment

0-15000
-400
-851.3
-501.3
-1019.3
-1396.9
-359.3
-362.3
-98.3
-102.3
-171.8
-275.5
-332.5
-324.6
-181.7
-458.4
-195.5
-170.2
-82
-97
-5.5
-20.6
-41.7
-101.4

cash-flows.row.common-stock-issued

00077.4
59.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
-59.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-495.9-1095.8-425
-413.7
-427.4
-355.7
-299.9
-271.8
-247.1
-222.6
-181.2
-169.9
-16.6
-22.5
-32.2
-23.7
-19.2
-16
-18.2
-19.3
-86.7
-1.5
-32.7
-1.1
-4.4
-6.9

cash-flows.row.other-financing-activites

0422-188.3-348
333
324.5
649.3
561
1804.2
900.3
470.9
318.6
204.4
63
118
234.3
321.7
254.1
593.6
254.9
242.5
328
177.9
5.3
3.8
305.6
336.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-224-1284.1-695.6
-480.8
-954.2
-207.7
-758.2
135.5
293.9
-114
39
-67.8
-125.4
-180
-130.4
-26.5
53.2
119.2
41.2
53
159.3
79.5
-32.9
-17.9
259.5
228.6

cash-flows.row.effect-of-forex-changes-on-cash

00.600
0
0
0
0
0
0.3
0
-0.3
-1
-5.7
0
0
-35.6
52.6
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0316.1-77473
94.9
45.5
-80.5
96.5
23.4
10.3
-14.2
91.5
-119.4
181.2
16.1
28.1
-26.5
53.2
-19.4
14
10.2
-14.9
13
-3.9
-42.3
-78.5
-29.5

cash-flows.row.cash-at-end-of-period

01104.2788.1865
392
297.1
251.7
332.1
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
-26.5
53.2
8.9
28.3
14.3
4.1
19
6.1
9.8
54.1
132.6

cash-flows.row.cash-at-beginning-of-period

0788.1865392
297.1
251.7
332.1
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
18.6
0
0
28.3
14.3
4.1
19
6
10
52.1
132.6
162.1

cash-flows.row.operating-cash-flow

0884.7863.11134.5
1192.3
1152.2
876.9
961.2
725.8
294.6
205.9
221.1
194.3
-55.1
160.4
166.2
92.3
120.9
158
92.2
13.2
45.5
32
117.7
29.1
-95.1
-217

cash-flows.row.capital-expenditure

0-348.1-491.6-600.7
-479.6
-293.1
-773.1
-185.5
-411.5
-400.1
-106.1
-190.4
-241.8
-88.8
-72.7
-79.1
-56.7
-258.3
-286.9
-119.4
-49.1
-57.9
-89.4
-88.7
-52.5
-241
-16.5

cash-flows.row.free-cash-flow

0536.6371.5533.8
712.7
859
103.9
775.7
314.2
-105.5
99.8
30.7
-47.5
-143.9
87.7
87.1
35.6
-137.4
-128.9
-27.2
-35.9
-12.4
-57.4
29
-23.3
-336.1
-233.5

Gelir Tablosu Satırı

Tonghua Dongbao Pharmaceutical Co., Ltd.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 600867.SS brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

03061.42778.53267.9
2892.2
2777.1
2692.9
2545.3
2040.4
1669.3
1451.3
1204.2
991.5
784.5
637.8
573.9
551
470
401.6
329.7
307.8
298.7
280.6
205.9
199.1
219.7
218.9
205.4
223.8
212.2
132

income-statement-row.row.cost-of-revenue

0689.7617.5575.7
588.4
721.5
745
644.5
491.9
412.9
452
385.4
357.3
295.4
243.4
245.2
262.2
242.2
217.7
192.3
168.5
151.1
138.1
116.8
103.3
79.8
59.7
57.3
62.8
49.5
0

income-statement-row.row.gross-profit

02371.62160.92692.2
2303.8
2055.6
1947.9
1900.9
1548.5
1256.4
999.3
818.8
634.2
489.1
394.3
328.7
288.9
227.8
184
137.4
139.3
147.6
142.4
89.1
95.8
139.9
159.2
148.1
161
162.7
132

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-5.6145.3171.8
99
121.9
-15.5
-13.2
20.2
1.3
3.1
6.2
18.2
4.1
8.5
27.8
7.3
11.7
3.4
2.8
3.3
1.3
2.4
5.2
11.5
23.9
17.3
0.3
0.9
0.5
0.2

income-statement-row.row.operating-expenses

01101.11270.41420.7
1163.9
1101.4
957.8
897.8
742.2
683.7
635.5
592.6
500.5
434.4
324
232.6
192.2
174.9
124.9
102.4
173.5
106.2
96.1
60.6
51.5
70.2
65.3
50.6
47.5
61.9
0.2

income-statement-row.row.cost-and-expenses

01790.91887.91996.3
1752.2
1822.9
1702.8
1542.3
1234
1096.6
1087.5
978
857.8
729.8
567.4
477.8
454.3
417.1
342.5
294.7
342
257.3
234.3
177.4
154.7
150
125
107.9
110.3
111.4
0.2

income-statement-row.row.interest-income

0-11.713.98.1
4.7
7.2
3.3
1.6
0.8
2.1
0.7
0.8
0.9
0.4
0.1
0.1
0.1
0.1
0.8
2.2
2.4
2.2
1.8
1.4
7.2
0
0
0
0
0
0

income-statement-row.row.interest-expense

04.50.30.2
10.2
20.6
13.5
15.5
44.6
18.2
27.5
17.6
13.8
16.6
22.5
32.2
23.7
19.3
16
16.2
17.4
6
0.7
0.3
0.3
-6.2
-2.4
-7.4
-3.6
-0.3
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

06.20.6-14.8
-72.5
-15.4
-12.6
-30
-47.4
-2.2
-40
-14.5
-66.7
372.2
128.5
-15.7
-31.3
34.1
-40.5
-14.4
-40
1.9
5.8
3
17.5
21.9
28.8
7.2
3.6
-1.5
-59.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-5.6145.3171.8
99
121.9
-15.5
-13.2
20.2
1.3
3.1
6.2
18.2
4.1
8.5
27.8
7.3
11.7
3.4
2.8
3.3
1.3
2.4
5.2
11.5
23.9
17.3
0.3
0.9
0.5
0.2

income-statement-row.row.total-operating-expenses

06.20.6-14.8
-72.5
-15.4
-12.6
-30
-47.4
-2.2
-40
-14.5
-66.7
372.2
128.5
-15.7
-31.3
34.1
-40.5
-14.4
-40
1.9
5.8
3
17.5
21.9
28.8
7.2
3.6
-1.5
-59.7

income-statement-row.row.interest-expense

04.50.30.2
10.2
20.6
13.5
15.5
44.6
18.2
27.5
17.6
13.8
16.6
22.5
32.2
23.7
19.3
16
16.2
17.4
6
0.7
0.3
0.3
-6.2
-2.4
-7.4
-3.6
-0.3
0

income-statement-row.row.depreciation-and-amortization

0207.1156.6156.1
84.9
171.6
172
166.5
160.4
130.8
112.8
108.3
107.6
106.7
103.5
89
72.8
69
64
57.9
48.9
46.9
37.9
27.1
26.5
30.9
17.2
-7.8
-4.6
-2.6
59.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01270.51828.91549.3
1180.7
967.8
993
986.2
738.9
569.2
327.4
206.6
49
423.1
190.4
52.7
58.3
75.5
22.6
22.3
-71.1
45.6
52.6
36.9
55.1
84.5
105.7
105.3
118.1
103.4
72.1

income-statement-row.row.income-before-tax

01276.71829.51534.5
1108.1
952.5
977.5
973
758.9
570.5
323.8
211.8
67.1
426.9
198.9
80.4
65.4
87
22.3
22.8
-70.9
45.1
53.5
36.8
64.2
100
122.8
105.2
118
101.6
72.2

income-statement-row.row.income-tax-expense

0198247.7225.9
177.8
142.9
138.6
132.9
119.7
80.5
47.3
32.3
7.4
63.9
25.5
12.7
20.9
11.4
9
4.8
3.9
6.9
9.2
5.7
16.2
28.4
32.2
14.5
36.5
33.5
23.8

income-statement-row.row.net-income

01167.81581.91308.3
929.9
811.2
838.6
836.6
640.9
493
279.8
183.9
62.7
364
178.4
73.7
46.8
77.4
12.1
16.2
-78.2
36.1
40
29.3
46.3
67.6
92.6
90.6
81.5
68.1
48.4

Sıkça Sorulan Sorular

Nedir Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) toplam varlıklar?

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) toplam varlıklar 7771366505.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir N/A'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.796'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 0.267'dur.

İşletme net kar marjı nedir?

Net kâr marjı 0.378'dir.

Firma toplam geliri nedir?

Toplam gelir 0.420'dur.

Nedir Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) net kar (net gelir)?

Net kar (net gelir) 1167835317.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 150000000.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 1101149964.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 0.000'tir.